US Stock MarketDetailed Quotes

AGXRW AGILE THERAPEUTICS INC C/WTS 13/10/2026 (TO PUR COM)

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Aug 13 16:00 ET
8.30KMarket Cap0.00P/E (TTM)

AGILE THERAPEUTICS INC C/WTS 13/10/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
1.33%5.58M
49.91%5.72M
80.02%19.59M
-9.56%3.61M
121.92%6.66M
158.84%5.5M
116.52%3.81M
165.40%10.88M
163.94%4M
133.26%3M
Operating revenue
1.33%5.58M
49.91%5.72M
80.02%19.59M
-9.56%3.61M
121.92%6.66M
158.84%5.5M
116.52%3.81M
165.40%10.88M
163.94%4M
133.26%3M
Cost of revenue
-35.15%1.5M
-16.13%1.68M
31.33%8.98M
32.55%2.19M
73.82%2.48M
3.41%2.31M
31.17%2M
-36.22%6.84M
-71.01%1.65M
-47.44%1.43M
Gross profit
27.66%4.08M
122.98%4.04M
162.23%10.62M
-39.27%1.42M
165.38%4.19M
3,143.81%3.2M
673.50%1.81M
161.18%4.05M
155.96%2.34M
210.74%1.58M
Operating expense
-17.98%6.83M
-20.25%6.79M
-32.94%30.5M
-40.62%5.48M
-10.67%8.19M
-26.31%8.32M
-46.11%8.52M
-29.36%45.48M
-49.25%9.22M
-36.15%9.16M
Selling and administrative expenses
-17.47%6.29M
-18.79%6.3M
-33.05%28.27M
-38.88%5.42M
-10.69%7.48M
-27.00%7.62M
-46.70%7.76M
-27.37%42.23M
-46.23%8.87M
-34.35%8.38M
-Selling and marketing expense
-17.37%3.78M
-21.16%3.68M
-41.49%17.77M
-45.53%3.73M
-13.67%4.8M
-38.33%4.57M
-55.75%4.67M
-30.10%30.37M
-48.06%6.85M
-40.76%5.56M
-General and administrative expense
-17.61%2.51M
-15.20%2.62M
-11.42%10.51M
-16.36%1.69M
-4.80%2.68M
0.76%3.05M
-22.82%3.09M
-19.31%11.86M
-38.92%2.02M
-16.49%2.82M
Research and development costs
-23.47%538K
-35.12%495K
-31.60%2.23M
-84.66%54K
-10.53%705K
-17.87%703K
-39.30%763K
-47.92%3.25M
-79.02%352K
-50.53%788K
Operating profit
46.43%-2.75M
58.90%-2.76M
52.01%-19.88M
41.09%-4.05M
47.27%-4M
55.03%-5.13M
56.93%-6.71M
41.65%-41.43M
69.24%-6.88M
51.91%-7.59M
Net non-operating interest income expense
107.84%28K
56.10%-162K
56.05%-1.34M
28.36%-288K
65.76%-328K
56.52%-357K
57.63%-369K
21.55%-3.05M
59.76%-402K
4.01%-958K
Non-operating interest income
86.67%28K
-30.30%23K
-2.50%78K
-43.33%17K
-71.74%13K
650.00%15K
3,200.00%33K
220.00%80K
2,900.00%30K
4,500.00%46K
Non-operating interest expense
--0
-53.98%185K
-54.68%1.42M
-29.40%305K
-66.04%341K
-54.80%372K
-53.90%402K
-20.01%3.13M
-56.80%432K
0.50%1M
Other net income (expense)
-646.83%-9.15M
149.14%4.2M
-53.05%6.76M
-103.88%-130K
35.00%3.53M
-76.26%1.67M
21.89%1.69M
276.22%14.4M
3.35M
2.61M
Gain on sale of security
-646.83%-9.15M
149.14%4.2M
-73.51%6.76M
-103.88%-130K
-74.31%3.53M
-76.26%1.67M
21.89%1.69M
566.84%25.52M
--3.35M
--13.74M
Special income (charges)
----
----
--0
--0
--0
----
----
---11.12M
--0
---11.12M
-Gain on sale of property,plant,equipment
----
----
--0
--0
--0
----
----
---11.12M
--0
---11.12M
Income before tax
-211.68%-11.87M
123.82%1.28M
51.92%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
64.21%-5.39M
57.66%-30.09M
79.87%-3.93M
64.64%-5.93M
Income tax
0
0
0
0
0
0
0
-4.68M
0
0
Net income
-211.68%-11.87M
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
Net income continuous Operations
-211.68%-11.87M
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
Minority interest income
Net income attributable to the parent company
-211.68%-11.87M
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-211.68%-11.87M
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 1.33%5.58M49.91%5.72M80.02%19.59M-9.56%3.61M121.92%6.66M158.84%5.5M116.52%3.81M165.40%10.88M163.94%4M133.26%3M
Operating revenue 1.33%5.58M49.91%5.72M80.02%19.59M-9.56%3.61M121.92%6.66M158.84%5.5M116.52%3.81M165.40%10.88M163.94%4M133.26%3M
Cost of revenue -35.15%1.5M-16.13%1.68M31.33%8.98M32.55%2.19M73.82%2.48M3.41%2.31M31.17%2M-36.22%6.84M-71.01%1.65M-47.44%1.43M
Gross profit 27.66%4.08M122.98%4.04M162.23%10.62M-39.27%1.42M165.38%4.19M3,143.81%3.2M673.50%1.81M161.18%4.05M155.96%2.34M210.74%1.58M
Operating expense -17.98%6.83M-20.25%6.79M-32.94%30.5M-40.62%5.48M-10.67%8.19M-26.31%8.32M-46.11%8.52M-29.36%45.48M-49.25%9.22M-36.15%9.16M
Selling and administrative expenses -17.47%6.29M-18.79%6.3M-33.05%28.27M-38.88%5.42M-10.69%7.48M-27.00%7.62M-46.70%7.76M-27.37%42.23M-46.23%8.87M-34.35%8.38M
-Selling and marketing expense -17.37%3.78M-21.16%3.68M-41.49%17.77M-45.53%3.73M-13.67%4.8M-38.33%4.57M-55.75%4.67M-30.10%30.37M-48.06%6.85M-40.76%5.56M
-General and administrative expense -17.61%2.51M-15.20%2.62M-11.42%10.51M-16.36%1.69M-4.80%2.68M0.76%3.05M-22.82%3.09M-19.31%11.86M-38.92%2.02M-16.49%2.82M
Research and development costs -23.47%538K-35.12%495K-31.60%2.23M-84.66%54K-10.53%705K-17.87%703K-39.30%763K-47.92%3.25M-79.02%352K-50.53%788K
Operating profit 46.43%-2.75M58.90%-2.76M52.01%-19.88M41.09%-4.05M47.27%-4M55.03%-5.13M56.93%-6.71M41.65%-41.43M69.24%-6.88M51.91%-7.59M
Net non-operating interest income expense 107.84%28K56.10%-162K56.05%-1.34M28.36%-288K65.76%-328K56.52%-357K57.63%-369K21.55%-3.05M59.76%-402K4.01%-958K
Non-operating interest income 86.67%28K-30.30%23K-2.50%78K-43.33%17K-71.74%13K650.00%15K3,200.00%33K220.00%80K2,900.00%30K4,500.00%46K
Non-operating interest expense --0-53.98%185K-54.68%1.42M-29.40%305K-66.04%341K-54.80%372K-53.90%402K-20.01%3.13M-56.80%432K0.50%1M
Other net income (expense) -646.83%-9.15M149.14%4.2M-53.05%6.76M-103.88%-130K35.00%3.53M-76.26%1.67M21.89%1.69M276.22%14.4M3.35M2.61M
Gain on sale of security -646.83%-9.15M149.14%4.2M-73.51%6.76M-103.88%-130K-74.31%3.53M-76.26%1.67M21.89%1.69M566.84%25.52M--3.35M--13.74M
Special income (charges) ----------0--0--0-----------11.12M--0---11.12M
-Gain on sale of property,plant,equipment ----------0--0--0-----------11.12M--0---11.12M
Income before tax -211.68%-11.87M123.82%1.28M51.92%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M64.21%-5.39M57.66%-30.09M79.87%-3.93M64.64%-5.93M
Income tax 0000000-4.68M00
Net income -211.68%-11.87M123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M
Net income continuous Operations -211.68%-11.87M123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M
Minority interest income
Net income attributable to the parent company -211.68%-11.87M123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -211.68%-11.87M123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data